The F.D.A. authorizes the Pfizer-BioNTech vaccine for children 12 to 15. Results from trials of Moderna’s vaccine in 12- to 17-year-olds are expected in the next few weeks. https://t.co/9CpCAUZTZN
Excited to share the @NEJM publication of the results of the @moderna_tx vaccine study. What a way to end 2020. Grateful to the study participants, my #PVTU research team and @PittPediatrics @PittCTSI @PittPlusMe https://t.co/w519Vu9t8f.
Should I be concerned to take my child to day care? What should I do if I think my child has multisystem inflammatory syndrome tied to #COVID19? What are the symptoms? @ChildrensPgh's Dr. Zac Aldewereld answers those questions. https://t.co/5wmoMAZqlF
Researchers around the world are searching for potential #coronavirus vaccines. @PittCVR Director Paul Duprex explains, the process of producing a vaccine takes months — even for a virus like influenza, which scientists have studied for decades.
https://t.co/uNNDtWbBU3
Very proud of the hard work and huge team effort needed to move this work out into the world beyond our Lab. Big thanks to @ATSBlueEditor@EFornoMD@AlcornLab, KollsLab, CeledonLab, ShapiroLab, WuLab and all of our collaborators and funding support.
Follistatin-like 1 Attenuation Causes Spontaneous Smoke-Resistant Pulmonary Emphysema | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://t.co/m5ekO5AxP0